Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

Similar articles for PubMed (Select 23319253)

1.

[Primary curative radiochemotherapy in nasopharyngeal carcinomas. Cumulative total cisplatin dose of prognostic significance].

Christiansen H, Wolff HA.

Strahlenther Onkol. 2013 Mar;189(3):269-70. doi: 10.1007/s00066-012-0285-y. German. No abstract available.

PMID:
23319253
2.

[Nasopharyngeal carcinoma: only irradiation or simultaneous radiochemotherapy?].

Grüner A, Grabenbauer GG, Rödel C, Weidenbecher M, Martus P, Iro H, Sauer R.

Strahlenther Onkol. 1999 Dec;175(12):591-6. German.

PMID:
10633784
3.

[Long-term efficacy of induction chemotherapy plus concurrent radiochemotherapy on advanced nasopharyngeal carcinoma].

Liang Y, Gao JM, Hu WH, Gao YH, Xie FY.

Ai Zheng. 2007 Aug;26(8):885-9. Chinese.

PMID:
17697553
4.

[Concomitant radiochemotherapy followed by adjuvant chemotherapy in patients with poorly differentiated nasopharyngeal cancer; tolerance and early results of treatment].

Kawecki A, Jagielska B, Jarzabski A, Szutkowski Z, Kiprian D, Rolski W, Pawłowska-Sendułka B.

Otolaryngol Pol. 2005;59(5):671-6. Polish.

PMID:
16471182
5.

Prognostic impact of tumor volumetry in patients with locally advanced head-and-neck carcinoma (non-nasopharyngeal) treated by radiotherapy alone or combined radiochemotherapy in a randomized trial.

Plataniotis GA, Theofanopoulou ME, Kalogera-Fountzila A, Haritanti A, Ciuleanou E, Ghilezan N, Zamboglou N, Dimitriadis A, Sofroniadis I, Fountzilas G.

Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1018-26.

PMID:
15234035
6.

Nasopharyngeal carcinomas: analysis of patient, tumor and treatment characteristics determining outcome.

Erkal HS, Serin M, Cakmak A.

Radiother Oncol. 2001 Dec;61(3):247-56. Review.

PMID:
11730993
8.

High-dose-rate brachytherapy as part of a multidisciplinary treatment of nasopharyngeal lymphoepithelioma in childhood.

Nakamura RA, Novaes PE, Antoneli CB, Fogaroli RC, Pellizzon AC, Ferrigno R, Maia MA, Salvajoli JV, Pereira AJ, Nishimoto IN.

Cancer. 2005 Aug 1;104(3):525-31.

9.

Concomitant infusion cisplatin and hyperfractionated radiotherapy for locally advanced nasopharyngeal and paranasal sinus tumors.

Choi KN, Rotman M, Aziz H, Sohn CK, Schulsinger A, Torres C, Har-El G, Chandra P, Bradley T, Rosenthal CJ.

Int J Radiat Oncol Biol Phys. 1997 Nov 1;39(4):823-9.

PMID:
9369129
10.

Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for local control.

Sze WM, Lee AW, Yau TK, Yeung RM, Lau KY, Leung SK, Hung AW, Lee MC, Chappell R, Chan K.

Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):21-7.

PMID:
15093895
11.

Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy.

Dunst J, Haensgen G.

Strahlenther Onkol. 2001 Dec;177(12):635-40. Review.

PMID:
11789401
12.

The role of neoadjuvant radiochemotherapy using low-dose fraction cisplatin and 5-fluorouracil in patients with carcinoma of the esophagus.

Nakano S, Baba M, Natsugoe S, Kusano C, Shimada M, Fukumoto T, Aikou T.

Jpn J Thorac Cardiovasc Surg. 2001 Jan;49(1):11-6.

PMID:
11233236
13.

Effect of Cisplatin on parotid gland function in concomitant radiochemotherapy.

Hey J, Setz J, Gerlach R, Vordermark D, Gernhardt CR, Kuhnt T.

Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1475-80. doi: 10.1016/j.ijrobp.2008.12.071. Epub 2009 Jun 8.

PMID:
19515505
14.

Concomitant chemotherapy and external radiotherapy plus brachytherapy for locally advanced esophageal cancer: results of a retrospective multicenter study.

Tessa M, Rotta P, Ragona R, Sola B, Grassini M, Nassisi D, Sciacero P, Airoldi M, Filippi A, Gianello L, De Angelis C, Ozzello F, Trotti AB, Ricardi U, Sannazzari GL.

Tumori. 2005 Sep-Oct;91(5):406-14.

PMID:
16459637
15.
16.

Toxicity of daily low dose cisplatin in radiochemotherapy for locally advanced head and neck cancer.

Wolff HA, Overbeck T, Roedel RM, Hermann RM, Herrmann MK, Kertesz T, Vorwerk H, Hille A, Matthias C, Hess CF, Christiansen H.

J Cancer Res Clin Oncol. 2009 Jul;135(7):961-7. doi: 10.1007/s00432-008-0532-x. Epub 2008 Dec 24.

17.

[Radiochemotherapy of head and neck cancers: dose reduction through the combination of cisplatin, bleomycin and tegafur].

Mishina H, Okuyama S, Yuasa R, Saijo S, Kaneko Y.

Gan To Kagaku Ryoho. 1985 Apr;12(4):947-50. Japanese.

PMID:
2580488
18.

Prognostic implications of hemoglobin levels before and after surgery as well as before and after radiochemotherapy for head and neck tumors.

Reichel O, Panzer M, Wimmer C, Dühmke E, Kastenbauer E, Suckfüll M.

Eur Arch Otorhinolaryngol. 2003 May;260(5):248-53. Epub 2002 Dec 4.

PMID:
12750913
19.

Postoperative radiochemotherapy with weekly cisplatin in patients with head and neck cancer single-institution outcome analysis.

Pala M, Odrazka K, Holeckova P, Vitek P, Kubes J, Podlesak T, Klozar J, Petruzelka L.

Neoplasma. 2012;59(2):129-36.

PMID:
22248269
20.

Concomitant radiochemotherapy of cervical cancer: is it justified to reduce the dosage of cisplatin?

Patyánik M, Nemeskéri C, Póti Z, Sinkó D, Pesznyák C, Király R, Kois R, Mayer A.

Strahlenther Onkol. 2009 Sep;185(9):582-7. doi: 10.1007/s00066-009-1974-z. Epub 2009 Sep 12.

PMID:
19756424
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk